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Ischemic	stroke	deprives	 basic	brain	metabolic	needs	of	oxygen	and	glucose.	 	Cerebral	 ischemia	
develops	 from	vascular	blocking	 lesions	 commonly	caused	by	atherosclerosis	 from	 lipid	aggregation	and	
inflammation.	 	According	 to	Holm	et	al. 	(2011),	 identified	cytosolic	 fatty	acid	binding	proteins	 are	thought	
to	play	an	important	 role	 in	macrophage	cholesterol	 interchange,	affiliated	 inflammation,	and	plaque	
instability. 	 Forty	percent	of	all	 ischemic	strokes	are	atherosclerotic	 in	nature	and	20	percent	are	due	to	
thrombi	or	emboli	 (fibrin,	 platelets,	 or	cholesterol	 crystals). 	
According	 to	Davis,	Miyares,	 and	Dietrich	 (2015),	excessive	circulating	lipids	 cause	endothelial	
dysfunction	by	accumulating	within	 extracellular	matrix	after	continued	exposure	 to	free	radicals,	 excess	
catecholamines,	and	inflammation	 increasing	 endothelium	permeability. 	 	Combinations	 of	 innate	and	
adaptive	 immune	systems,	 vascular	smooth	muscle	proliferation,	 and	remodeling	 of	extracellular	matrix	
create	atherosclerotic	plaque.		Plaque	 rupture	 leads	 to	a	cascade	of	events:
v Platelets	 activate	following	a	plaque	 rupture	 forming	a	thrombus.
v Consecutively	platelets	 adhere	to	 the	endothelial	 site	 injury	 inhibiting	 excess	blood	 loss	 creating	
a	plug	 formation	of	thrombin	and	 thromboplastin.
v Following	 adhesion	 to	 injury	site	platelets	 become	activated	with	 the	assistance	of	 local	tissue	
factor	and	release	 agonists	 thromboxane	A2	and	adenosine	diphosphate	 (ADP)	 from	platelet	
granules	 to	enhance	aggregation.
v G	protein	contributes	 by	activating	glycoprotein	 IIb/II Ia enhancing	the	thrombotic	response.
v Activated	platelets	prompt	glycoprotein	 IIb/II Ia receptors,	crosslinking	nearby	platelets	
functioning	 like	nets	 to	trap	additional	 blood	cells	and	debris.
v Cascade	of	events	induces	 thrombus	 growth	as	additional	 platelets	 release	additional	
thromboplastic	 fibrin	 proteins.
v Thrombus	growth	 reduces	 the	lumen	diameter	restricting	 blood	 flow	causing	 ischemia	(figure	2). 		
v Ischemic	neuron	cells	 lead	to	ATP	 loss	and	glutamine	 release	 from	synapses	causing	sodium	and	
calcium	ion	gate	porosity.	 	
v Reactive	oxygen	species	and	 inflammation	 lead	to	cytotoxicity-mediated	cytokines.	
v Microglia	cells	produce	 inflammatory	cytokines,	 including	 interleuklin-1β	 (IL-β)	and	TNF-α	(an	
immunomodulatory	molecule	 linked	 to	atherosclerosis	 and	stroke),	 cascading	to	cell	death	
activated	by	apoptosis.
Neurological	 functioning	may	alter	with	a	70	percent	 reduction	 in	blood	 flow.		However,	patients	 can	
remain	asymptomatic	until	 there	 is	a	sudden	reduction	 in	blood	 flow	created	by	a	complete	obstruction.	 	
When	 the	brain	 is	not	adequately	perfused	with	blood	and	deprived	of	oxygen	and	glucose	as	well	as	
failure	 to	 remove	lactic	acid	and	carbon	dioxide,	nerve	cells	begin	 to	die.	 	Local	edema	results,	
compressing	capillaries	 enlarging	 the	 ischemic	area	and	 reducing	neuronal	 activity.		Blood	 flow	 is	 still	
sufficient	 to	keep	tissue	alive	as	witness	 by	symptom	recovery	as	oxygenated	blood	 flow	 is	 increased.		
However,	 if	 swelling	 is	 severe,	 symptoms	of	increased	 intracranial	pressure	 may	occur.		Various	
neurological,	 neuropsychiatric,	and	neuropsychological	abnormities	 result	depending	 on	length	of	time	
and	exact	location	of	ischemia.		Complete	blood	deprivation	greater	 than	three	minutes	produce	
neuronal,	 glial,	 and	vascular	necrosis	 and	irreversible	 brain	damage.	A	 full	 symptomatic	infarct	may	take	
minutes,	 hours,	or	even	days	 to	develop.	 	
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Stroke	affects	men	and	women	equally	
in	 the	United	States,	predominantly	
ischemic	stroke.	 	Oxidative	stress	and	brain	
inflammation	contribute	 to	the	
pathophysiology	 of	cerebral	 injury	 leading	
to	cell	apoptosis	 and	death	(Pascotini et	
al. ,	2015).		Immune	responses	within	 the	
CNS	and	systemic	inflammatory	events	
play	 important	roles	 in	 the	progression,	
repair	and	stroke	recovery.		
Decreasing	modifiable	 risk	 factors,	
public	education	and	recognition,	 along	
with	 rapid	 relief	of	an	arterial	occlusion	 to	
restoration	 of	prevalent	blood	 flow	will	
decrease	the	morbidity	and	mortality	
associated	with	 ischemic	stroke.		For	every	
minute	of	treatment	delay,	1.9	million	
neurons,	 14	billion	 synapses	and	12	km	of	
myelinated	 fibers	are	destroyed	 (Musuka
et	al. ,	2015,	p.	891).		
Research	 to	reduce	door	 to	 treatment	
times	continues.	According	to	Aston	
(2015),	 collaboration	between	hospitals	
and	EMS	providers	proved	beneficial	by	
reducing	 time	to	 treatment.	Current	
research	 is	examining	benefits	of	placing	
CT	scanners	in	ambulances	with	
telemedicine	support	 to	paramedics	
administering	 tPA enroute.		Field	 tPA
administration	 will	 facilitate	a	direct	
angiography	approach	replacing	 time	
spent	 in	ED’s	 (Musuka et	al. ,	2015).		
The	ASA	 recommends	genetic	and	
pharmacogenetic testing	 for	future	
research	 in	stroke	prevention	 (Meschia et	
al. ,	2014).	
A	66	year-old	Caucasian	 female	arrives	via	EMS	at	12:25	pm	with	stroke	presentation.	 	Care	 team,	including	 a	physician,	 await	patient	arrival	at	the	bedside.	 	Background	
history:	11:00	am,	the	patient’s	 spouse	 ran	an	errand.		He	returned	55	minutes	 later	 finding	her	 lying	on	the	 floor.		The	patient	exhibited	slurred	 speech,	 right	 facial	droop,	
and	 right	hemiplegia	 with	a	National	 Institutes	of	Health	Stroke	Scale	(NIHSS)	of	19	upon	arrival. 		No	apparent	signs	 of	trauma	noted.	 	Medical	history	 includes	 three	positive	
modifiable	 risk	 factors:	diabetes	 mellitus,	 hyperlipidemia,	 and	hypertension.	 	Current	medications	 include:	Metformin,	Hydrochlorothiazide,	 and	Simvastatin.		Physical	exam	
is	unremarkable	with	B/P	146/86,	HR	82,	R	18,	99%	SPO2	on	 room	air. 		
A	 standard	brain	attack	treatment	order	set	was	utilized.	 	Lab	results	 within	normal	 limits	 include:	electrolytes,	 renal,	 complete blood	 count	with	platelet	count,	 cardiac	
markers,	prothrombin	 time,	 international	 normalized	 ration,	and	activated	thromboplastin	 time.		Blood	 glucose	was	elevated	at 120	mg/dL.		CT	scan	at	12:35	pm	with	 12:40	
pm	read	 indicating	absence	of	 intracranial	hemorrhage.		
The	patient	has	no	contraindications	 to	 tissue	plasminogen	 activator	(tPA)	and	the	patient’s	 spouse	 agrees	to	 treatment	after	outweighing	 risks	and	potential	benefits	 of	
tPA administration.	 	Drug	was	administered	 at	1:00	pm,	120	minutes	after	the	patient	was	 last	 seen	normal.	Drug	administration	 was	complete	at	2:00	upon	admission	 to	 the	
stroke	unit. 		During	the	 first	24	hours	 the	patient	 regained	strength	 in	 the	right	upper	and	 lower	extremities.		 Facial	droop and	slurred	 speech	resolved,	 sensory	exam	is	
normal	and	repeat	CT	scan	 is	negative	prior	 to	discharge.
Summary:		The	patient’s	 modifiable	 risk	 factors	were	well	 controlled	 with	current	medications.	 	A	positive	outcome	resulted	 from	rapid	 identification	 by	the	spouse,	
calling	911,	and	arriving	within	 85	minutes	 from	 last	known	normal	permitted	 tPA administration	 as	established	 by	the	American	Heart	Association	 (AHA)/American	 Stroke	
Association	 (ASA)	guidelines	 of	within	 three	hours	of	symptom	onset.		National	 Institutes	of	Neurological	Disorders	 and	Stroke	(NINDS)	has	established	 time	 frames	for	ED	
stroke	care	(Jauchet	al. ,	2013).		A	positive	 outcome	resulted	 from	use	of	a	standard	 treatment	order	 set	 (handout),	and	guidelines	 established	 by	AHA/ASA	 and	NINDS.
As	an	advance	practice	nurse	(APN),	a	 thorough	understanding	of	 the	sequela	 of	modifiable	 risk	 factors	 such	as	 long-term	
coronary	artery	disease,	 left	ventricular	hypertrophy,	congestive	heart	failure,	 hypertension,	 atrial	 fibrillation,	 diabetes,	
smoking,	dyslipidemia,	 carotid	stenosis,	 sickle	cell	disease,	 postmenopausal	 hormone	 therapy,	diet,	and	obesity	cannot	be	
overemphasized.	 		Hyperglycemia	amplifies	 the	degree	of	severity	of	ischemic	 injury	contributing	 to	poor	neurological	 recovery	
and	should	be	closely	monitored	by	routine	HbA1C	 testing.	 	Hypertension	 reduces	arterial	elasticity,	 erodes	endothelial	 cell	
lining	 and	induces	 roughening	of	vessel	walls	 making	HTN	the	leading	 risk	 factor	for	 stroke	and	should	 be	measured	 routinely	
(Meschia et	al. ,	2014).		Reducing	modifiable	 risk	 factors	such	as	HTN,	hypercholesterolemia,	 smoking,	physical	 inactivity	and	
obesity,	 should	begin	with	education.	
Education	utilizing	 e-health	and	mobile	messaging	 tools	 could	include	 recognition	of	early	signs	 and	symptoms	of	this	 life-
altering	event	to	 reduce	morbidly	and	mortality	associated	with	a	stroke	as	well	 as	strict	 instructions	 to	call	Emergency	Medical	
Services	(EMS)	(Rasura et	al. ,	2014).		Patients	arriving	within	 three	hours	of	symptoms	achieved	better	outcomes	than	 those	
seeking	delayed	care.		
Stroke	symptoms	appear	as	 sudden	onset	of	
neurologic	deficits. 	 Individuals	experiencing	any	of	the	
following	 symptoms	should	seek	medical	care	
immediately:	
v sudden	weakness	of	 the	face,	arm,	or	 leg,	most	
often	on	one	side	of	the	body
v hemiparesis
v diplopia
v bulbar	palsies
v dysphagia
v unilateral	 dysmetria and	 incoordination
v reduced	level	of	 consciousness.	
Introduction
Stroke	is	 the	 leading	cause	of	
functional	 impairment	 in	 the	
United	States.		Annually,	 795,000	
stokes	occur	with	a	mean	lifetime	
cost	estimated	at	$140,000	per	
person	 (Meschia et	al. ,	2014).		
Every	40	seconds	someone	suffers	
a	stroke,	 while	every	240	seconds	
a	stroke	death	occurs	(Niemi,	
McErlane,	&	Tillett,	 2013).		
Stroke	is	 the	broad	 term	often	
used	 to	describe	a	neurological	
emergency,	of	either	 ischemic	or	
hemorrhagic	etiology,	 affecting	
blood	 flow	to	 the	brain.	 	Both	are	
medical	emergencies	 requiring	
time	sensitive	medical	
intervention	 (Elder,	 Lemon,	&	
Costello,	 2015).	Treatment	
modalities	 are	comprehensively	
different;	 therefore,	being	able	to	
differentiate	early	 signs	and	
symptoms	are	imperative	 for	
healthcare	professionals. 	 	
Neurovascular	 imaging	is	
required	 to	differentiate	between	
an	ischemic	or	a	hemorrhagic	
stroke.		Use	of	a	non-contrast	
computed	tomography	(CT)	 is	 fast	
and	 readily	available	 to	rule	out	
hemorrhagic	stroke	or	 rule	 in	a	
major	 ischemic	stroke.		Magnetic	
resonance	 imaging	(MRI)	has	
greater	spatial	 resolution	 to	
diagnose	minor	 ischemic	strokes.
The	topic	of	ischemic	stroke	
was	chosen	 in	the	 interest	of	an	
upcoming	Joint	Commission	
Primary	Stroke	Center	 (PSC)	
accreditation	survey.
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HANDOUT
Use of Standard Treatment Order Set
According to Elder et al. “Current guidelines for ischemic stroke advocate the use of intravenous (tPA), the early use of thromboembolism (VTE) 
prophylaxis, anticoagulation in patient with atrial fibrillation (afib), and lipid lowering therapy.” (2015, para. 1).  The Joint Commission (JC) requires eight 
mandatory standards and two optional standards for hospitals to receive Primary Stroke Center (PSC) status:
v Venous thromboembolism (VTE) prophylaxis
v Anticoagulation therapy for afib or flutter
v Thrombolytic therapy
v Antithrombotic therapy by end of hospital day two
v Discharged on statin therapy
v Discharged on antithrombotic therapy
v Receive stroke education
v Assessment for rehabilitation
v Screening for dysphagia
v Smoking cessation services
Order sets ensure compliance with quality indicators, decrease length of stay and decrease overall costs.  Order sets created by multidisciplinary 
stroke experts should follow American Heart Association (AHA)/American Stroke Association (ASA) guidelines.  Incorporating order sets in the electronic 
medical records (EMR) whenever possible will prevent modifications or exclusions.  Elder et al. (2015) performed a retrospective study reporting that 
adherence to national guidelines increased with standard order set use.  Current AHA stroke guidelines recommend Emergency Medical Service (EMS) 
transport suspected stroke patients to the closest PSC unless contraindicated (Jauch et al., 2013) .  
